Tyrosinemia Type 1 Latest Advances

Correction: Kuypers et al. Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide. Int. J. Neonatal Screen. 2024, 10, 82.

Journal: International journal of neonatal screening

Published: June 27, 2025

Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines.

Journal: Journal of inherited metabolic disease

Published: June 24, 2025

Hereditary Tyrosinemia Type 1: Success and Challenges in Indian Subcontinent.

Journal: Indian pediatrics

Published: June 16, 2025

Evaluation of the Performance of Newborn Screening for Tyrosinemia Type 1 in The Netherlands: Suggestions for Improvements Using Additional Biomarkers in Addition to Succinylacetone.

Journal: International journal of neonatal screening

Published: April 09, 2025

Integrating Machine Learning and Follow-Up Variables to Improve Early Detection of Hepatocellular Carcinoma in Tyrosinemia Type 1: A Multicenter Study.

Journal: International journal of molecular sciences

Published: March 06, 2025

Progress in Gene Therapy for Hereditary Tyrosinemia Type 1.

Journal: Pharmaceutics

Published: February 10, 2025

An Unusual Presentation of Tyrosinemia Type 1 in a Pediatric Patient: Case Report and Comprehensive Review.

Journal: Clinical case reports

Published: January 16, 2025

Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide.

Journal: International journal of neonatal screening

Published: November 07, 2024

Identification of the Mutations Spectrum in the Fumarylacetoacetate Hydrolase Gene in Tyrosinemia Type 1 Patients in Northeastern Iran.

Journal: Biochemical genetics

Published: August 06, 2024

Hypophosphatemic Rickets as a Key Sign for the Diagnosis of Hereditary Tyrosinemia Type 1: Case Reports and Narrative Review of the Literature.

Journal: Revista medica de Chile

Published: August 02, 2024

Clinical, Biochemical, and Molecular Characteristics of Filipino Patients with Tyrosinemia Type 1.

Journal: International journal of neonatal screening

Published: July 18, 2024

Oxidative Stress Associated With Increased Reactive Nitrogen Species Generation in the Liver and Kidney Caused by a Major Metabolite Accumulating in Tyrosinemia Type 1.

Journal: Cell biochemistry and function

Published: June 25, 2024

Filters

Correction: Kuypers et al. Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide. Int. J. Neonatal Screen. 2024, 10, 82.

Correction: Kuypers et al. Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide. Int. J. Neonatal Screen. 2024, 10, 82.

Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines.

Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines.

Hereditary Tyrosinemia Type 1: Success and Challenges in Indian Subcontinent.

Hereditary Tyrosinemia Type 1: Success and Challenges in Indian Subcontinent.

Evaluation of the Performance of Newborn Screening for Tyrosinemia Type 1 in The Netherlands: Suggestions for Improvements Using Additional Biomarkers in Addition to Succinylacetone.

Evaluation of the Performance of Newborn Screening for Tyrosinemia Type 1 in The Netherlands: Suggestions for Improvements Using Additional Biomarkers in Addition to Succinylacetone.

Integrating Machine Learning and Follow-Up Variables to Improve Early Detection of Hepatocellular Carcinoma in Tyrosinemia Type 1: A Multicenter Study.

Integrating Machine Learning and Follow-Up Variables to Improve Early Detection of Hepatocellular Carcinoma in Tyrosinemia Type 1: A Multicenter Study.

Progress in Gene Therapy for Hereditary Tyrosinemia Type 1.

Progress in Gene Therapy for Hereditary Tyrosinemia Type 1.

An Unusual Presentation of Tyrosinemia Type 1 in a Pediatric Patient: Case Report and Comprehensive Review.

An Unusual Presentation of Tyrosinemia Type 1 in a Pediatric Patient: Case Report and Comprehensive Review.

Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide.

Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide.

Identification of the Mutations Spectrum in the Fumarylacetoacetate Hydrolase Gene in Tyrosinemia Type 1 Patients in Northeastern Iran.

Identification of the Mutations Spectrum in the Fumarylacetoacetate Hydrolase Gene in Tyrosinemia Type 1 Patients in Northeastern Iran.

Hypophosphatemic Rickets as a Key Sign for the Diagnosis of Hereditary Tyrosinemia Type 1: Case Reports and Narrative Review of the Literature.

Hypophosphatemic Rickets as a Key Sign for the Diagnosis of Hereditary Tyrosinemia Type 1: Case Reports and Narrative Review of the Literature.

Clinical, Biochemical, and Molecular Characteristics of Filipino Patients with Tyrosinemia Type 1.

Clinical, Biochemical, and Molecular Characteristics of Filipino Patients with Tyrosinemia Type 1.

Oxidative Stress Associated With Increased Reactive Nitrogen Species Generation in the Liver and Kidney Caused by a Major Metabolite Accumulating in Tyrosinemia Type 1.

Oxidative Stress Associated With Increased Reactive Nitrogen Species Generation in the Liver and Kidney Caused by a Major Metabolite Accumulating in Tyrosinemia Type 1.